Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02315 BIOCYTOGEN-B
RT Nominal up52.600 +1.650 (+3.238%)
Shareholder's Disclosure of Interests
Disclosure of Interest   ｜   Fund Raising   ｜   Share Repurchase
Date Shareholder name Reason of Disclosure Buy/Sell and
Involved Shares		 Average Price per share Current Holdings % of Issued Shares
11/02/20261201(L)-2,605,000(L)HKD39.797(L)6,283,580(L)5.67
10/02/2026InnoVeda Medtech, Ltd.1201(L)-361,500(L)HKD50.671(L)15,468,900(L)13.96
10/02/2026Prowell Ventures Pte Ltd1201(L)-361,500(L)HKD50.671(L)15,468,900(L)13.96
10/02/2026Yang Zhi1201(L)-361,500(L)HKD50.671(L)15,468,900(L)13.96
10/02/2026GIC Special Investments Private Limited1201(L)-361,500(L)HKD50.671(L)15,468,900(L)13.96
10/02/2026GIC Private Limited1201(L)-361,500(L)HKD50.671(L)15,468,900(L)13.96
10/02/2026BVCF Realization Fund GP, Ltd.1201(L)-361,500(L)HKD50.671(L)15,468,900(L)13.96
10/02/2026BVCF Realization Fund, L.P.1201(L)-361,500(L)HKD50.671(L)15,468,900(L)13.96
10/02/2026GIC (Ventures) Pte. Ltd.1201(L)-361,500(L)HKD50.671(L)15,468,900(L)13.96
10/02/2026BioVeda China Fund II RMB, Limited1201(L)-361,500(L)HKD50.671(L)15,468,900(L)13.96
02/02/20261101(L)+786,000(L)HKD27.278(L)8,888,580(L)8.02
20/01/20261201(L)-1,162,000(L)16,549,544(L)14.94
20/01/20261201(L)-1,142,500(L)16,569,044(L)14.96
20/01/2026CMB International Private Investment Limited1201(L)-1,142,500(L)16,569,044(L)14.96
20/01/20261201(L)-1,162,000(L)16,549,544(L)14.94
20/01/2026Astral Eminent Limited1201(L)-1,142,500(L)16,569,044(L)14.96
20/01/2026CMBI Private Equity Series SPC1201(L)-1,142,500(L)16,569,044(L)14.96
20/01/2026CMBI Private Equity Series SPC1201(L)-1,162,000(L)16,549,544(L)14.94
20/01/2026CMB International Private Investment Limited1201(L)-1,162,000(L)16,549,544(L)14.94
20/01/20261201(L)-1,142,500(L)16,569,044(L)14.96
20/01/20261201(L)-1,162,000(L)16,549,544(L)14.94
20/01/20261201(L)-1,142,500(L)16,569,044(L)14.96
20/01/2026Astral Eminent Limited1201(L)-1,162,000(L)16,549,544(L)14.94
20/01/2026CMB International Investment Management Limited1201(L)-1,142,500(L)16,569,044(L)14.96
20/01/2026CMB International Investment Management Limited1201(L)-1,162,000(L)16,549,544(L)14.94
12/01/2026Li Yan1102(L)5,040(L)5,040(L)0.01
12/01/2026Li Yan1201(L)-1,000(L)HKD41.080(L)4,040(L)0.00
07/01/2026LAKE BLEU CAPITAL (Hong Kong) LIMITED1201(L)-81,500(L)HKD36.143(L)5,538,600(L)4.99
06/01/2026CMB International Private Investment Limited1201(L)-929,500(L)17,711,544(L)15.99
06/01/2026CMBI Private Equity Series SPC1201(L)-929,500(L)17,711,544(L)15.99
06/01/2026CMB International Investment Management Limited1201(L)-929,500(L)17,711,544(L)15.99
06/01/20261201(L)-929,500(L)17,711,544(L)15.99
06/01/20261201(L)-929,500(L)17,711,544(L)15.99
06/01/20261201(L)-929,500(L)17,711,544(L)15.99
06/01/2026Astral Eminent Limited1201(L)-929,500(L)17,711,544(L)15.99
10/12/20251213(L)23,519,160(L)23,519,160(L)7.00
10/12/20251704(L)14,296,320(L)4.25
10/12/20251213(L)23,519,160(L)7.00
10/12/2025CMB International Investment Management Limited1201(L)-1,292,500(L)18,641,044(L)16.83
10/12/20251201(L)-1,292,500(L)18,641,044(L)16.83
 1   2   3  
Remark: (L) - Long Position, (S) - Short Position, (P) Lending;
  Real time quote last updated: 20/02/2026 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.